171 related articles for article (PubMed ID: 33372933)
21. Desmoid tumor of the abdominal wall A case report and literature review.
Guttadauro A; Maternini M; Frassani S; Guanziroli E; Lo Bianco G; Gabrielli F
Ann Ital Chir; 2017 Nov; 6():. PubMed ID: 29424372
[TBL] [Abstract][Full Text] [Related]
22. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
[TBL] [Abstract][Full Text] [Related]
23. Lower Rate of CTNNB1 Mutations and Higher Rate of APC Mutations in Desmoid Fibromatosis of the Breast: A Series of 134 Tumors.
Norkowski E; Masliah-Planchon J; Le Guellec S; Trassard M; Courrèges JB; Charron-Barra C; Terrier P; Bonvalot S; Coindre JM; Laé M
Am J Surg Pathol; 2020 Sep; 44(9):1266-1273. PubMed ID: 32590455
[TBL] [Abstract][Full Text] [Related]
24. Isolated desmoid tumor of pancreatic tail with cyst formation diagnosed by beta-catenin immunostaining: a rare case report with review of literature.
Rao RN; Agarwal P; Rai P; Kumar B
JOP; 2013 May; 14(3):296-301. PubMed ID: 23669485
[TBL] [Abstract][Full Text] [Related]
25. [Familial adenomatous polyposis, desmoid tumors and Gardner syndrome].
Tayeb Tayeb C; Parc Y; Andre T; Lopez-Trabada Ataz D
Bull Cancer; 2020 Mar; 107(3):352-358. PubMed ID: 31882269
[TBL] [Abstract][Full Text] [Related]
26. Desmoid tumors: clinical features and treatment options: a case report and a review of literature.
Jenayah AA; Bettaieb H; Saoudi S; Gharsa A; Sfar E; Boudaya F; Chelli D
Pan Afr Med J; 2015; 21():93. PubMed ID: 26516394
[TBL] [Abstract][Full Text] [Related]
27. Is mutation analysis of β-catenin useful for the diagnosis of desmoid-type fibromatosis? A systematic review.
Sakai T; Hamada S; Koike H; Shimizu K; Yoshida M; Nishida Y
Jpn J Clin Oncol; 2020 Sep; 50(9):1037-1042. PubMed ID: 32533146
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical staining with non-phospho β-catenin as a diagnostic and prognostic tool of COX-2 inhibitor therapy for patients with extra-peritoneal desmoid-type fibromatosis.
Sakai T; Nishida Y; Hamada S; Koike H; Ikuta K; Ota T; Ishiguro N
Diagn Pathol; 2017 Aug; 12(1):66. PubMed ID: 28851389
[TBL] [Abstract][Full Text] [Related]
29. [Intraabdominal desmoid tumors].
Vida Pérez L; Martínez Rivas F
Med Clin (Barc); 2013 Oct; 141(7):314-9. PubMed ID: 23809408
[No Abstract] [Full Text] [Related]
30. Multifocal desmoid tumor in childhood: report of two cases and review of the literature.
Weyl Ben Arush M; Meller I; Moses M; Klausner J; Isakov J; Kuten A; el Hassid R
Pediatr Hematol Oncol; 1998; 15(1):55-61. PubMed ID: 9509506
[TBL] [Abstract][Full Text] [Related]
31. The Evolving Management of Desmoid Fibromatosis.
Prendergast K; Kryeziu S; Crago AM
Surg Clin North Am; 2022 Aug; 102(4):667-677. PubMed ID: 35952695
[TBL] [Abstract][Full Text] [Related]
32. Desmoid-Type Fibromatosis: Evolving Treatment Standards.
Fiore M; MacNeill A; Gronchi A; Colombo C
Surg Oncol Clin N Am; 2016 Oct; 25(4):803-26. PubMed ID: 27591500
[TBL] [Abstract][Full Text] [Related]
33. [Mesogastric desmoid tumor, a rare entity].
Lapaille L; Mutijima E; Loly C
Rev Med Liege; 2020 Jul; 75(7-8):548-552. PubMed ID: 32779910
[TBL] [Abstract][Full Text] [Related]
34. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
35. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
[TBL] [Abstract][Full Text] [Related]
36. [Extra-abdominal desmoid tumors. Diagnostic-therapeutic considerations and review of the literature].
Barrios RH; Leyes M; Losada JI; Schweitzer D; Amillo S
Rev Med Univ Navarra; 1995; 39(1):14-20. PubMed ID: 14735713
[TBL] [Abstract][Full Text] [Related]
37. [Therapeutic options for aggressive fibromatosis].
Altmann S; Lenz-Scharf O; Schneider W
Handchir Mikrochir Plast Chir; 2008 Apr; 40(2):88-93. PubMed ID: 18437666
[TBL] [Abstract][Full Text] [Related]
38. Evolving strategies for management of desmoid tumor.
Riedel RF; Agulnik M
Cancer; 2022 Aug; 128(16):3027-3040. PubMed ID: 35670122
[TBL] [Abstract][Full Text] [Related]
39. An unusual finding in a desmoid-type fibromatosis of the pancreas: a case report and review of the literature.
Torres JC; Xin C
J Med Case Rep; 2018 May; 12(1):123. PubMed ID: 29751773
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
